BeautyHealth appoints Stephen J. Fanning to Board; former Hydrafacial Chairman

SkinHealth Systems Inc.

Stephen Fanning appointed to BeautyHealth board effective Dec 12, 2024; joins Audit & Nominating committees.
Fanning served as Hydrafacial Chairman from 2016-2020 prior to its IPO; led Solta Medical (Thermage, Fraxel).
Recent roles include CEO of Spectrum Solutions and Z-Medica; previously held senior roles at Johnson & Johnson.
Board now has eight directors; Fanning qualifies as independent under Nasdaq rules.
Compensation follows standard non-employee director package as disclosed in April 2024 proxy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.